🇺🇸 enfuvirtide [Fuzeon] in United States

4 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Injection Site Rash — 1 report (25%)
  2. Rash Erythematous — 1 report (25%)
  3. Rash Macular — 1 report (25%)
  4. Rash Pruritic — 1 report (25%)

Source database →

enfuvirtide [Fuzeon] in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is enfuvirtide [Fuzeon] approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for enfuvirtide [Fuzeon] in United States?

Hoffmann-La Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.